Please provide your email address to receive an email when new articles are posted on . For the TARGET trial, presented at the American College of Cardiology Scientific Session and simultaneously ...
NEW ORLEANS, LA — Entry to a large randomized clinical-outcomes trial was stopped early after its data and safety monitoring board (DSMB) saw a significant jump in early mortality in patients ...
The use of an intracoronary hemodynamic technique, such as FRACTIONAL FLOW RESERVE (FFR), to determine the severity of a stenosis, can help when deciding whether to perform percutaneous coronary ...
The benefit of fractional flow reserve (FFR)–guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains ...
FAMOUS-NSTEMI is the latest clinical trial to assess benefits of St. Jude Medical PressureWireTM technology in expanded patient populations ST. PAUL, Minn. & BARCELONA, Spain -- St. Jude Medical, Inc.
In a field that has grown accustomed to the idea of physiological assessment—particularly fractional flow reserve (FFR) to guide decisions to perform or defer revascularization—new data released today ...
LONDON--(BUSINESS WIRE)--The fractional flow reserve devices market is expected to grow by USD 446.64 million, progressing at a CAGR of over 12% during the forecast period. Click & Get Free Sample ...
LONDON--(BUSINESS WIRE)--The fractional flow reserve devices market is poised to grow by USD 446.64 million during 2020-2024, progressing at a CAGR of about 12% during the forecast period. Request ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results